Ruth Arnon

3.1k total citations
73 papers, 2.5k citations indexed

About

Ruth Arnon is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ruth Arnon has authored 73 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 23 papers in Immunology and 15 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ruth Arnon's work include Monoclonal and Polyclonal Antibodies Research (15 papers), Immunotherapy and Immune Responses (10 papers) and Glycosylation and Glycoproteins Research (9 papers). Ruth Arnon is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (15 papers), Immunotherapy and Immune Responses (10 papers) and Glycosylation and Glycoproteins Research (9 papers). Ruth Arnon collaborates with scholars based in Israel, United States and Germany. Ruth Arnon's co-authors include Michael Sela, Dvora Teitelbaum, Rina Aharoni, Sara Fuchs, Masha Fridkis‐Hareli, Zeev Lando, Gertrude E. Perlmann, Israel Pecht, Raya Eilam and Zvi Fishelson and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Ruth Arnon

72 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruth Arnon Israel 28 1.0k 765 536 459 213 73 2.5k
Sylvie Fournier Canada 30 970 1.0× 567 0.7× 229 0.4× 172 0.4× 195 0.9× 62 2.6k
Judy M. Teale United States 37 1.5k 1.4× 824 1.1× 876 1.6× 522 1.1× 229 1.1× 113 3.3k
Alexander Miller United States 22 1.7k 1.7× 1.1k 1.4× 178 0.3× 1.1k 2.4× 241 1.1× 53 3.1k
Konrad Reske Germany 21 1.4k 1.3× 768 1.0× 114 0.2× 293 0.6× 191 0.9× 54 2.4k
Christopher J. Krco United States 35 1.6k 1.6× 829 1.1× 109 0.2× 615 1.3× 165 0.8× 85 3.6k
Brigitte Devaux United States 15 1.4k 1.3× 845 1.1× 61 0.1× 240 0.5× 311 1.5× 32 2.6k
William A. Rees United States 23 1.2k 1.2× 852 1.1× 230 0.4× 116 0.3× 235 1.1× 59 2.7k
Anneliese Schimpl Germany 37 4.3k 4.2× 1.4k 1.9× 258 0.5× 462 1.0× 511 2.4× 96 6.0k
Bénédicte Manoury France 27 1.3k 1.3× 839 1.1× 128 0.2× 136 0.3× 331 1.6× 52 2.5k
Ari Hinkkanen Finland 33 753 0.7× 986 1.3× 176 0.3× 121 0.3× 485 2.3× 85 3.1k

Countries citing papers authored by Ruth Arnon

Since Specialization
Citations

This map shows the geographic impact of Ruth Arnon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth Arnon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth Arnon more than expected).

Fields of papers citing papers by Ruth Arnon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth Arnon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth Arnon. The network helps show where Ruth Arnon may publish in the future.

Co-authorship network of co-authors of Ruth Arnon

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth Arnon. A scholar is included among the top collaborators of Ruth Arnon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth Arnon. Ruth Arnon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aharoni, Rina, Ron Milo, & Ruth Arnon. (2024). Glatiramer Acetate for the Treatment of Multiple Sclerosis: From First-Generation Therapy to Elucidation of Immunomodulation and Repair. Pharmacological Reviews. 76(6). 1133–1158. 2 indexed citations
2.
Real‐Fernández, Feliciana, Francesca Nuti, Roberta Lanzillo, et al.. (2022). Role of Helical Structure in MBP Immunodominant Peptides for Efficient IgM Antibody Recognition in Multiple Sclerosis. Frontiers in Chemistry. 10. 885180–885180. 1 indexed citations
3.
Arnon, Ruth. (2016). Translational Neuroimmunology in Multiple Sclerosis : From Disease Mechanisms to Clinical Applications. Elsevier eBooks. 1 indexed citations
4.
Niv, Eva, et al.. (2014). Sequential capsule endoscopy of the small bowel for follow-up of patients with known Crohn's disease. Journal of Crohn s and Colitis. 8(12). 1616–1623. 59 indexed citations
5.
Yablecovitch, Doron, Maytal Shabat-Simon, Rina Aharoni, et al.. (2011). Beneficial Effect of Glatiramer Acetate Treatment on Syndecan-1 Expression in Dextran Sodium Sulfate Colitis. Journal of Pharmacology and Experimental Therapeutics. 337(2). 391–399. 10 indexed citations
6.
Ben-Yedidia, Tamar, Hadar Marcus, Yaīr Reisner, & Ruth Arnon. (1999). Intranasal administration of peptide vaccine protects human/mouse radiation chimera from influenza infection. International Immunology. 11(7). 1043–1051. 47 indexed citations
7.
Schechter, Bilha, et al.. (1999). Organ Selective Delivery Using a Tissue-Directed Sreptavidin-Biotin System: Targeting 5-Fluorouridine via TNP-Streptavidin. Journal of drug targeting. 6(5). 337–348. 8 indexed citations
8.
Ben-Yedidia, Tamar, et al.. (1998). Efficacy of anti-influenza peptide vaccine in aged mice. Mechanisms of Ageing and Development. 104(1). 11–23. 34 indexed citations
9.
Grene, Edith, et al.. (1997). Relationship between Antigenicity and Immunogenicity of Chimeric Hepatitis B Virus Core Particles Carrying HIV Type 1 Epitopes. AIDS Research and Human Retroviruses. 13(1). 41–51. 12 indexed citations
10.
Arnon, Ruth. (1996). The development of Cop 1 (Copaxone®), and innovative drug for the treatment of multiple sclerosis: personal reflections. Immunology Letters. 50(1-2). 1–15. 72 indexed citations
11.
Teitelbaum, Dvora, Masha Fridkis‐Hareli, Ruth Arnon, & Michael Sela. (1996). Copolymer 1 inhibits chronic relapsing experimental allergic encephalomyelitis induced by proteolipid protein (PLP) peptides in mice and interferes with PLP-specific T cell responses. Journal of Neuroimmunology. 64(2). 209–217. 126 indexed citations
12.
Arnon, Ruth, et al.. (1996). Synthetic Recombinant Vaccine Induces Anti-Influenza Long-Term Immunity and Cross-Strain Protection. Advances in experimental medicine and biology. 397. 23–29. 5 indexed citations
13.
Arnon, Ruth & Raphael Levi. (1995). Synthetic Recombinant Vaccines against Viral Agents. International Archives of Allergy and Immunology. 108(4). 321–326. 8 indexed citations
14.
Schechtman, Deborah, Daniela Ram, Rebeca Tarrab‐Hazdai, Ruth Arnon, & Israël Schechter. (1995). Stage-specific expression of the mRNA encoding a 14-3-3 protein during the life cycle of Schistosoma mansoni. Molecular and Biochemical Parasitology. 73(1-2). 275–278. 19 indexed citations
15.
Parizade, Miriam, Ruth Arnon, P J Lachmann, & Zvi Fishelson. (1994). Functional and antigenic similarities between a 94-kD protein of Schistosoma mansoni (SCIP-1) and human CD59.. The Journal of Experimental Medicine. 179(5). 1625–1636. 59 indexed citations
16.
Orr, Nadav, Ruth Arnon, G. James Rubin, et al.. (1994). Enhancement of anti-Shigella lipopolysaccharide (LPS) response by addition of the cholera toxin B subunit to oral and intranasal proteosome-Shigella flexneri 2a LPS vaccines. Infection and Immunity. 62(11). 5198–5200. 14 indexed citations
17.
Aharoni, Rina, et al.. (1991). Immunomodulation of experimental allergic encephalomyelitis by antibodies to the antigen–Ia complex. Nature. 351(6322). 147–150. 79 indexed citations
18.
Levi‐Schaffer, Francesca, Rebeca Tarrab‐Hazdai, Haim Meshulam, & Ruth Arnon. (1984). Effect of phosphonium salts and phosphoranes on the acetylcholinesterase activity and on the viability of Schistosoma mansoni parasites. International Journal of Immunopharmacology. 6(6). 619–627. 15 indexed citations
19.
Abramsky, Oded, Dvora Teitelbaum, Cynthia Webb, & Ruth Arnon. (1975). Neuritogenic and Encephalitogenic Properties of the Peripheral Nerve Basic Proteins. Journal of Neuropathology & Experimental Neurology. 34(1). 36–45. 33 indexed citations
20.
Pruzanski, W. & Ruth Arnon. (1965). CYSTINE AND OTHER AMINOACIDS IN FINGERNAILS OF CYSTINURIC PATIENTS. The Lancet. 286(7402). 60–61. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sylvie Fournier Breakdown of academic impact, for papers by Judy M. Teale Breakdown of academic impact, for papers by Alexander Miller Breakdown of academic impact, for papers by Konrad Reske Breakdown of academic impact, for papers by Christopher J. Krco Breakdown of academic impact, for papers by Brigitte Devaux Breakdown of academic impact, for papers by William A. Rees Breakdown of academic impact, for papers by Anneliese Schimpl Breakdown of academic impact, for papers by Bénédicte Manoury Breakdown of academic impact, for papers by Ari Hinkkanen
Rankless by CCL
2026